$APYP 01/31/2021 Following the public disclosure
Post# of 96
https://www.sleepxclear.com/investors
We believe that the acquisition should provide significant value for all parties and allow the DreamIT X3, our principal anti-snoring product, to reach the market as early as the first half of 2022 under the “Wellness Gadgets” category, which will allow for a shorter time for the market.